Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 9Neoplasm Metastasis 7Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Recurrence 2Prostatic Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Tongue Neoplasms 1Thymoma 1Skin Neoplasms 1Salivary Gland Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Laryngeal Neoplasms 1Hypoxia 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Gliosarcoma 1

Interventions

Cisplatin 9Cetuximab 6Radiotherapy, Intensity-Modulated 5Docetaxel 4Radiotherapy 3Fluorouracil 3Carboplatin 3pembrolizumab 2durvalumab 2Radiation 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2sodium thiosulfate 1gossypol acetic acid 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Pilocarpine 1Oral Hygiene 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Laryngeal Neoplasms × NVP-BKM120 × Clear all
NCT02113878 2024-11-05

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Dana-Farber Cancer Institute

Phase 1 Completed
23 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡